{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:53:56Z","timestamp":1790214836405,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK 089,507"],"award-info":[{"award-number":["P30 DK 089,507"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002319"],"award-info":[{"award-number":["UL1TR002319"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2024\/ GNT2036793"],"award-info":[{"award-number":["2024\/ GNT2036793"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL171034"],"award-info":[{"award-number":["R01-HL171034"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["GUIMBE23Y5"],"award-info":[{"award-number":["GUIMBE23Y5"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012308","name":"National Jewish Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010956","name":"State University of New York Upstate Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007928","name":"Perelman School of Medicine, University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["TAYLOR19Y3"],"award-info":[{"award-number":["TAYLOR19Y3"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["MAYFLOWER-TAYLOR21A0"],"award-info":[{"award-number":["MAYFLOWER-TAYLOR21A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["JAIN21A0"],"award-info":[{"award-number":["JAIN21A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008893","name":"University of Iowa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006458","name":"Children's Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jcf.2025.07.015","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:34:56Z","timestamp":1754408096000},"page":"1058-1066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-7426","authenticated-orcid":false,"given":"Sylvia","family":"Szentpetery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4602-8490","authenticated-orcid":false,"given":"Dara","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair J.","family":"Blumenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3230-1935","authenticated-orcid":false,"given":"Carmen","family":"Luna-Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-3053","authenticated-orcid":false,"given":"Carlos","family":"Milla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6044-4824","authenticated-orcid":false,"given":"Elena K.","family":"Schneider-Futschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne S","family":"Sheffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Darrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A","family":"Flume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-2297","authenticated-orcid":false,"given":"Kimberly E","family":"Foil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher N.","family":"Fortner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0514-8536","authenticated-orcid":false,"given":"Jennifer S.","family":"Guimbellot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne D.","family":"Lyerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Mayer-Hamblett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-0644","authenticated-orcid":false,"given":"Clement L.","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6872-7155","authenticated-orcid":false,"given":"Jacquelyn","family":"Spano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8019-9811","authenticated-orcid":false,"given":"Emma M.","family":"Tillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-8044","authenticated-orcid":false,"given":"Aaron","family":"Trimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Wilfond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5436-9722","authenticated-orcid":false,"given":"Jennifer L.","family":"Taylor-Cousar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcf.2025.07.015_bib0001","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.pcl.2023.06.003","article-title":"Newborn Screening","volume":"70","author":"Pappas","year":"2023","journal-title":"Pediatr Clin North Am"},{"issue":"10408","key":"10.1016\/j.jcf.2025.07.015_bib0002","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis","volume":"402","author":"Taylor-Cousar","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2025.07.015_bib0003","unstructured":"Ivacaftor (Kalydeco), United States Prescribing Information. https:\/\/pi.vrtx.com\/files\/uspi_ivacaftor.pdf."},{"key":"10.1016\/j.jcf.2025.07.015_bib0004","unstructured":"Lumacaftor\/ivacaftor (Orkambi) United States Prescribing Information. https:\/\/pi.vrtx.com\/files\/uspi_lumacaftor_ivacaftor.pdf."},{"key":"10.1016\/j.jcf.2025.07.015_bib0005","unstructured":"Elexacaftor\/tezacaftor\/ivacaftor (Trikafta) United States Prescribing Information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/212273s004lbl.pdf."},{"key":"10.1016\/j.jcf.2025.07.015_bib0006","unstructured":"Vanzacaftor tezacaftor d ivacaftor United States Prescribing Information [Available from: https:\/\/pi.vrtx.com\/files\/uspi_vanzacaftor_tezacaftor_deutivacaftor.pdf."},{"issue":"2","key":"10.1016\/j.jcf.2025.07.015_bib0007","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ppul.26209","article-title":"Detection of disease-causing CFTR variants in state newborn screening programs","volume":"58","author":"McGarry","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.jcf.2025.07.015_bib0008","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.suc.2022.07.016","article-title":"Meconium Ileus, distal intestinal obstruction syndrome, and other gastrointestinal pathology in the cystic fibrosis patient","volume":"102","author":"Tobias","year":"2022","journal-title":"Surg Clin North Am"},{"issue":"485","key":"10.1016\/j.jcf.2025.07.015_bib0009","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7531","article-title":"In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis","volume":"11","author":"Sun","year":"2019","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.jcf.2025.07.015_bib0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jcf.2021.03.018","article-title":"Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy","volume":"20","author":"Fortner","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2025.07.015_bib0011","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jcf.2022.04.005","article-title":"A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2025.07.015_bib0012","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jcf.2024.06.003","article-title":"Clinical outcomes of two infants with cystic fibrosis, including presence of the vas deferens, born to a woman with cystic fibrosis taking CFTR modulators during both pregnancies","volume":"23","author":"Kowalik","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2025.07.015_bib0013","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ajpath.2020.01.009","article-title":"Phenotypic characterization and comparison of cystic fibrosis rat models generated using CRISPR\/Cas9 gene editing","volume":"190","author":"McCarron","year":"2020","journal-title":"Am J Pathol"},{"issue":"19\u201320","key":"10.1016\/j.jcf.2025.07.015_bib0014","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/hum.2022.036","article-title":"Recombinant adeno-associated virus-mediated editing of the G551D cystic fibrosis transmembrane conductance regulator mutation in Ferret airway basal cells","volume":"33","author":"Yan","year":"2022","journal-title":"Hum Gene Ther"},{"issue":"8","key":"10.1016\/j.jcf.2025.07.015_bib0015","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157229","article-title":"In utero and postnatal ivacaftor\/lumacaftor therapy rescues multiorgan disease in CFTR-F508del ferrets","volume":"9","author":"Evans","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcf.2025.07.015_bib0016","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on nasal potential difference and lung function in Phe508del rats","volume":"15","author":"Reyne","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcf.2025.07.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116155","article-title":"Fetal drug exposure after maternally administered CFTR modulators Elexacaftor\/Tezacaftor\/Ivacaftor in a rat model","volume":"171","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"10.1016\/j.jcf.2025.07.015_bib0018","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/bph.16417","article-title":"Extent of foetal exposure to maternal elexacaftor\/tezacaftor\/ivacaftor during pregnancy","volume":"181","author":"Li","year":"2024","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.015_bib0019","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jcf.2024.11.014","article-title":"Lens-related ocular changes in fetal rats following in-utero exposure to elexacaftor-tezacaftor-ivacaftor","volume":"24","author":"Zhu","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.015_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcf.2024.09.007","article-title":"CF ferrets exposed to in utero ivacaftor do not develop lens abnormalities","volume":"24","author":"Taylor-Cousar","year":"2025","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2025.07.015_bib0021","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1165\/rcmb.2022-0175LE","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor disrupts Respiratory tract development in a murine fetal lung explant model","volume":"67","author":"Lhuillier","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jcf.2025.07.015_bib0022","unstructured":"Cunningham F.G., Leveno K.J., Dashe J.S., Hoffman B.L., Spong C.Y., Casey B.M. Williams obstetrics, 26e. New York, NY: McGraw Hill; 2022."},{"issue":"1","key":"10.1016\/j.jcf.2025.07.015_bib0023","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e31818d6788","article-title":"Medications in pregnancy and lactation: part 1","volume":"113","author":"Buhimschi","year":"2009","journal-title":"Teratol. Obs. Gynecol"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.015_bib0024","doi-asserted-by":"crossref","first-page":"51 e1-8","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.jcf.2025.07.015_bib0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.c.30313","article-title":"Evolving knowledge of the teratogenicity of medications in human pregnancy","volume":"157C","author":"Adam","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.jcf.2025.07.015_bib0026","unstructured":"Task Force on Research Specific to Pregnant Women and Lactating Women (\u201cTask Force\u201d or \u201cPRGLAC\u201d) 2018 [Available from: https:\/\/www.nichd.nih.gov\/sites\/default\/files\/2018-09\/PRGLAC_Report.pdf."},{"key":"10.1016\/j.jcf.2025.07.015_bib0027","unstructured":"Tezacaftor\/ivacaftor (Symdeko) United States Prescribing Information."},{"issue":"6","key":"10.1016\/j.jcf.2025.07.015_bib0028","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jcf.2018.05.009","article-title":"Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding","volume":"17","author":"Trimble","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.07.015_bib0029","article-title":"Drug exposure to infants born to mothers taking Elexacaftor, Tezacaftor, and Ivacaftor","author":"Collins","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"18","key":"10.1016\/j.jcf.2025.07.015_bib0030","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jcf.2025.07.015_bib0031","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"10212","key":"10.1016\/j.jcf.2025.07.015_bib0032","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jcf.2025.07.015_bib0033","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-2600(24)00411-9","article-title":"Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials","volume":"13","author":"Keating","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2025.07.015_bib0034","unstructured":"Cystic Fibrosis Foundation. 2023 Annual Data Report Balitmore, Maryland: Cystic Fibrosis Foundation; 2024 [Available from: https:\/\/www.cff.org\/medical-professionals\/patient-registry."},{"key":"10.1016\/j.jcf.2025.07.015_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2020.02.018","article-title":"Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators - an international survey","author":"Nash","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2025.07.015_bib0036","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jcf.2021.03.006","article-title":"Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation","volume":"20","author":"Taylor-Cousar","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2025.07.015_bib0037","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.chest.2024.09.019","article-title":"Impact of cystic fibrosis transmembrane conductance regulator modulators on maternal outcomes during and after pregnancy","volume":"167","author":"Jain","year":"2025","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jcf.2025.07.015_bib0038","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jcf.2022.10.004","article-title":"Congenital bilateral cataracts in newborns exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breast feeding","volume":"21","author":"Jain","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.07.015_bib0039","article-title":"Pregnancy in cystic fibrosis: review of the literature and expert recommendations","author":"Jain","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2025.07.015_bib0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jcf.2023.10.022","article-title":"A provider survey assessing fetal impact of CFTR modulator use in males with CF during assisted and unassisted reproduction and partner pregnancy","volume":"23","author":"Taylor-Cousar","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.015_bib0041","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001289","article-title":"Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design","volume":"9","author":"Jain","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jcf.2025.07.015_bib0042","unstructured":"https:\/\/stanfordhealthcare.org\/content\/dam\/SHC\/health-care-professionals\/medical-staff\/policies\/innovative-care-guidelines-final-3-18-11-copy.pdf [Available from: https:\/\/stanfordhealthcare.org\/content\/dam\/SHC\/health-care-professionals\/medical-staff\/policies\/innovative-care-guidelines-final-3-18-11-copy.pdf."},{"issue":"6","key":"10.1016\/j.jcf.2025.07.015_bib0043","doi-asserted-by":"crossref","first-page":"B9","DOI":"10.1016\/j.ajog.2021.09.001","article-title":"Society for Maternal-Fetal Medicine Special Statement: beyond the scalpel: in utero fetal gene therapy and curative medicine","volume":"225","author":"Shanahan","year":"2021","journal-title":"Am J Obs. Gynecol"},{"issue":"1","key":"10.1016\/j.jcf.2025.07.015_bib0044","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pd.6276","article-title":"Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: detection of the 50 most common disease-causing variants","volume":"43","author":"Jeppesen","year":"2023","journal-title":"Prenat Diagn"},{"issue":"Suppl 7","key":"10.1016\/j.jcf.2025.07.015_bib0045","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1093\/cid\/ciu709","article-title":"Designing drug trials: considerations for pregnant women","volume":"59 Suppl 7","author":"Sheffield","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcf.2025.07.015_bib0046","unstructured":"International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH)-E21: Inclusion of Pregnant and Breast-feeding Individuals in Clinical Trials [Available from: https:\/\/database.ich.org\/sites\/default\/files\/ICH_E21_Final_Concept_Paper_2023_1106_MCApproved.pdf."},{"key":"10.1016\/j.jcf.2025.07.015_bib0047","unstructured":"Rhophylac United States Prescribing Information [Available from: https:\/\/www.fda.gov\/media\/75013\/download."},{"issue":"18","key":"10.1016\/j.jcf.2025.07.015_bib0048","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2025.07.015_bib0049","unstructured":"ABRYSVO United States Prescribing Information [Available from: https:\/\/www.fda.gov\/media\/168889\/download."}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325015383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325015383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:35:12Z","timestamp":1779953712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325015383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1569199325015383"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.07.015","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}